L'uso del CCNU nella chemioterapia dei tumori del sistema nervoso centrale.

D. Adinolfi; L. Pavesi; G. Robustelli della Cuna; P. Paoletti

L'uso del CCNU nella chemioterapia dei tumori del sistema nervoso centrale.

Translated title of the contribution: CCNU in the chemotherapy of tumours of the central nervous system (author's transl)

D. Adinolfi, L. Pavesi, G. Robustelli della Cuna, P. Paoletti

Istituti Clinici Scientifici Maugeri Spa – Società Benefit

Research output: Contribution to journal › Article › peer-review

Abstract

This study concerns 59 patients with primary and metastatic tumors of the CNS. After surgery, each patients followed a therapeutic protocol requiring Radiotherapy (5500 Rads for 6 weeks) and antiblastic monochemotherapy with CCNU (130 MG/M2/D p.o. every 8 weeks). The results were evaluated according to Wilson's (1975) criteria of response to therapy. CCNU significantly improved the survival time in comparison to the data given for conventional treatment.

Translated title of the contribution	CCNU in the chemotherapy of tumours of the central nervous system (author's transl)
Original language	Italian
Pages (from-to)	191-195
Number of pages	5
Journal	Rivista di Patologia Nervosa e Mentale
Volume	98
Issue number	3
Publication status	Published - May 1977

ASJC Scopus subject areas

Medicine(all)

Cite this

@article{c7b7ef241a384a2fa56e5cec1691c0f2,

title = "L'uso del CCNU nella chemioterapia dei tumori del sistema nervoso centrale.",

abstract = "This study concerns 59 patients with primary and metastatic tumors of the CNS. After surgery, each patients followed a therapeutic protocol requiring Radiotherapy (5500 Rads for 6 weeks) and antiblastic monochemotherapy with CCNU (130 MG/M2/D p.o. every 8 weeks). The results were evaluated according to Wilson's (1975) criteria of response to therapy. CCNU significantly improved the survival time in comparison to the data given for conventional treatment.",

author = "D. Adinolfi and L. Pavesi and {Robustelli della Cuna}, G. and P. Paoletti",

year = "1977",

month = may,

language = "Italian",

volume = "98",

pages = "191--195",

journal = "Rivista di Patologia Nervosa e Mentale",

issn = "0035-6433",

number = "3",

}

TY - JOUR

T1 - L'uso del CCNU nella chemioterapia dei tumori del sistema nervoso centrale.

AU - Adinolfi, D.

AU - Pavesi, L.

AU - Robustelli della Cuna, G.

AU - Paoletti, P.

PY - 1977/5

Y1 - 1977/5

N2 - This study concerns 59 patients with primary and metastatic tumors of the CNS. After surgery, each patients followed a therapeutic protocol requiring Radiotherapy (5500 Rads for 6 weeks) and antiblastic monochemotherapy with CCNU (130 MG/M2/D p.o. every 8 weeks). The results were evaluated according to Wilson's (1975) criteria of response to therapy. CCNU significantly improved the survival time in comparison to the data given for conventional treatment.

AB - This study concerns 59 patients with primary and metastatic tumors of the CNS. After surgery, each patients followed a therapeutic protocol requiring Radiotherapy (5500 Rads for 6 weeks) and antiblastic monochemotherapy with CCNU (130 MG/M2/D p.o. every 8 weeks). The results were evaluated according to Wilson's (1975) criteria of response to therapy. CCNU significantly improved the survival time in comparison to the data given for conventional treatment.

UR - http://www.scopus.com/inward/record.url?scp=0017485091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017485091&partnerID=8YFLogxK

M3 - Articolo

C2 - 616020

AN - SCOPUS:0017485091

VL - 98

SP - 191

EP - 195

JO - Rivista di Patologia Nervosa e Mentale

JF - Rivista di Patologia Nervosa e Mentale

SN - 0035-6433

IS - 3

ER -

L'uso del CCNU nella chemioterapia dei tumori del sistema nervoso centrale.

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this